Curnutte John T 4
4 · PORTOLA PHARMACEUTICALS INC · Filed Mar 5, 2019
Insider Transaction Report
Form 4
Curnutte John T
Executive Vice President
Transactions
- Tax Payment
Common Stock
2019-03-04$33.41/sh−6,446$215,361→ 98,539 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Performance Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).